Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pro Dex (PDEX) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Pro Dex (PDEX) over the last 13 years, with Q4 2025 value amounting to $338000.0.

  • Pro Dex's Gains from Investment Securities fell 7898.01% to $338000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $2.1 million, marking a year-over-year decrease of 4547.55%. This contributed to the annual value of $4.5 million for FY2025, which is 13569.54% up from last year.
  • According to the latest figures from Q4 2025, Pro Dex's Gains from Investment Securities is $338000.0, which was down 7898.01% from $2000.0 recorded in Q3 2025.
  • In the past 5 years, Pro Dex's Gains from Investment Securities registered a high of $3.2 million during Q2 2021, and its lowest value of -$149000.0 during Q3 2021.
  • Over the past 5 years, Pro Dex's median Gains from Investment Securities value was $520000.0 (recorded in 2025), while the average stood at $630921.1.
  • Per our database at Business Quant, Pro Dex's Gains from Investment Securities plummeted by 23925.23% in 2021 and then surged by 913076.92% in 2022.
  • Pro Dex's Gains from Investment Securities (Quarter) stood at $6500.0 in 2021, then soared by 9130.77% to $600000.0 in 2022, then increased by 10.0% to $660000.0 in 2023, then surged by 143.64% to $1.6 million in 2024, then plummeted by 78.98% to $338000.0 in 2025.
  • Its last three reported values are $338000.0 in Q4 2025, $2000.0 for Q3 2025, and $1.3 million during Q2 2025.